Results 101 to 110 of about 14,341 (209)
Archives of Medicine and Health Sciences, 2013 Extramedullary hematopoiesis (EMH) is the development of hematopoietic tissue outside the bone marrow and it most often occurs in the liver and spleen. Renal EMH is quite rare, and there are very few case reports concerning the kidney. We describe a case
Basharat Mubeen +4 more
doaj +1 more source
A Lucky Mistake: The Splenic Glands of Marcello Malpighi [PDF]
, 2017 PURPOSE OF THE REVIEW: More than 50% of all gynaecological cancers can be classified as rare tumours (defined as an annual incidence of
Chaviano, Felicia +3 more
core +1 more source
Erythropoiesis in health and disease: Distinguishing defective and ineffective erythropoiesis
HemaSphere, Volume 10, Issue 1, January 2026.Abstract Erythropoiesis is a finely regulated process ensuring continuous red blood cell production to maintain oxygen delivery. Disruptions in this process give rise to defective erythropoiesis, characterized by impaired lineage commitment and progenitor development, and ineffective erythropoiesis (IE), marked by expansion of erythroid progenitors ...
Sara El Hoss +3 more
wiley +1 more source
Marrow adipose tissue expansion coincides with insulin resistance in MAGP1-deficient mice [PDF]
, 2016 Marrow adipose tissue (MAT) is an endocrine organ with the potential to influence skeletal remodeling and hematopoiesis. Pathologic MAT expansion has been studied in the context of severe metabolic challenge, including caloric restriction, high fat diet ...
Abou-Ezzi, Grazia +8 more
core +3 more sources
Hematological Oncology, Volume 44, Issue 1, January 2026.ABSTRACT In the AVALON cohort of relapsed/refractory AML treated with venetoclax plus hypomethylating agents, NPM1 and IDH1/2 mutations showed no significant impact on response or survival. These findings indicate that prognostic models for relapsed AML should consider treatment context rather than baseline mutation status.
Calogero Vetro +22 more
wiley +1 more source
Elranatamab Exposure–Safety Analysis in Relapsed or Refractory Multiple Myeloma
The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.Abstract Elranatamab, a bispecific antibody targeting B‐cell maturation antigen, is approved for the treatment of relapsed or refractory multiple myeloma (RRMM). An exposure–safety analysis was conducted using the data from patients with RRMM across four clinical studies, MagnetisMM‐1, 2, 3, and 9 (NCT03269136, NCT04798586, NCT04649359, and NCT05014412)
Pooneh Soltantabar +5 more
wiley +1 more source
Veterinary Medicine and Science, Volume 12, Issue 1, January 2026.Safety of tolfenamic acid in Japanese quails. ABSTRACT Objective This study evaluated the safety profile of tolfenamic acid following repeated oral administration in Japanese quails (Coturnix coturnix japonica) at doses of 2 and 8 mg/kg every 12 h for 7 days. Methods The 42 quails were randomly assigned to three groups. The first group (n = 6) received
Fatih Hatipoglu +6 more
wiley +1 more source
Integrative Zoology, Volume 21, Issue 1, Page 104-115, January 2026.ABSTRACT The ongoing invasion of the zoonotic parasite Angiostrongylus cantonensis threatens humans, other mammals, and birds. In Mallorca, neurological disorders associated with this parasite are increasingly reported in free‐living Algerian hedgehogs, Atelerix algirus, raising public health concerns.
Anna Šipková +7 more
wiley +1 more source
Video-assisted thoracoscopic surgery for intrathoracic extramedullary hematopoiesis
Journal of Minimal Access Surgery, 2007 Extramedullary hematopoiesis is a rare cause of an intrathoracic mass in individuals with hemolytic disorders. It can be clinically confused with other tumors of the mediastinum.
Giblin E, Frankel K, Mortman K
doaj
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study
European Journal of Haematology, Volume 116, Issue 1, Page 23-30, January 2026.ABSTRACT Momelotinib, a novel JAK1/2 inhibitor with inhibitory activities on activin A receptor type I, has shown breakthrough clinical efficacy in patients with myelofibrosis (MF) and anemia, a disease‐related manifestation of challenging management. In this retrospective real‐life multicenter Italian study, we investigated the safety and efficacy of ...
Maria Carmen Martorelli +34 more
wiley +1 more source